Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the ‘Company’ or ‘Sona’) is pleased to announce further positive interim results from its study with The Giacomantonio Immuno-Oncology Research Group at Dalhousie University (the ‘Study’). The Company was provided with data from the Study that indicates the response in a pre-clinical triple…
A recent report from McKinsey highlights the critical role of commodities trading amid heightened uncertainty, particularly as new players…
Overview West High Yield (TSXV:WHY) is an exploration and development mining company focusing on critical minerals with a high-grade…
Cyclone Metals Limited (ASX: CLE) (Cyclone or the Company) is pleased to announce the release of an upgraded JORC…
Ramp Metals (TSXV:RAMP) specializes in battery and base metals, particularly nickel and lithium with three properties, two situated in…
Highlights Crawford on track for mid-2025 construction decision and first production by year-end 2027 Front End Engineering Design led…
Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to announce the appointment of…
White Cliff Minerals Limited (White Cliff or the Company) is pleased to provide an update on planned work at…
Overview Cyclone Metals (ASX:CLE) is a listed exploration and development mining company focused on developing a world-class iron ore…